These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34619099)

  • 61. The Effects of Border Shutdowns on the Spread of COVID-19.
    Kang N; Kim B
    J Prev Med Public Health; 2020 Sep; 53(5):293-301. PubMed ID: 33070499
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Interrupting transmission of COVID-19: lessons from containment efforts in Singapore.
    Lee VJ; Chiew CJ; Khong WX
    J Travel Med; 2020 May; 27(3):. PubMed ID: 32167146
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 omicron infection and related hospital admission among people with substance use disorder in Hong Kong: a matched case-control study.
    Huang C; Wei Y; Yan VKC; Ye X; Kang W; Yiu HHE; Shami JJP; Cowling BJ; Tse ML; Castle DJ; Chui CSL; Lai FTT; Li X; Wan EYF; Wong CKH; Hayes JF; Chang WC; Chung AKK; Lau CS; Wong ICK; Chan EW
    Lancet Psychiatry; 2023 Jun; 10(6):403-413. PubMed ID: 37141907
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Seroprevalence of SARS-CoV-2 in Hong Kong returnees.
    Hanage WP; Vincent VI; Low NM
    Lancet Microbe; 2020 Aug; 1(4):e147. PubMed ID: 33521713
    [No Abstract]   [Full Text] [Related]  

  • 65. Seroprevalence of SARS-CoV-2 in Hong Kong returnees - Authors' reply.
    To KK; Yuen KY
    Lancet Microbe; 2020 Aug; 1(4):e148. PubMed ID: 33521714
    [No Abstract]   [Full Text] [Related]  

  • 66. Genomic epidemiology of Delta SARS-CoV-2 during transition from elimination to suppression in Aotearoa New Zealand.
    Jelley L; Douglas J; Ren X; Winter D; McNeill A; Huang S; French N; Welch D; Hadfield J; de Ligt J; Geoghegan JL
    Nat Commun; 2022 Jul; 13(1):4035. PubMed ID: 35821124
    [TBL] [Abstract][Full Text] [Related]  

  • 67. COVID-19 and Long-Term Care Policy for Older People in Hong Kong.
    Lum T; Shi C; Wong G; Wong K
    J Aging Soc Policy; 2020; 32(4-5):373-379. PubMed ID: 32476597
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Impact of travel ban implementation on COVID-19 spread in Singapore, Taiwan, Hong Kong and South Korea during the early phase of the pandemic: a comparative study.
    Gwee SXW; Chua PEY; Wang MX; Pang J
    BMC Infect Dis; 2021 Aug; 21(1):799. PubMed ID: 34380452
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Broader trauma: Considerations for COVID-19 psychosocial interventions in Hong Kong.
    Miu AS; Cheung CN; Tsang KKY; Chan BSB; Poon LT; Fung IC
    Asian J Psychiatr; 2020 Oct; 53():102358. PubMed ID: 32854071
    [No Abstract]   [Full Text] [Related]  

  • 70. Key Considerations in the Recovery and Resumption of Surgical Services after the COVID-19 Pandemic.
    Tan YQ; Lu J; Wang Z; Tiong HY; Chiong E
    Ann Acad Med Singap; 2020 Nov; 49(11):922-924. PubMed ID: 33381790
    [No Abstract]   [Full Text] [Related]  

  • 71. Patients With Genetic Heart Disease and COVID-19: A Cardiac Society of Australia and New Zealand (CSANZ) Consensus Statement.
    Gray B; Semsarian C; Fatkin D; Ingles J; Atherton JJ; Davis AM; Sanders P; Pachter N; Skinner JR; Stiles MK;
    Heart Lung Circ; 2020 Jul; 29(7):e85-e87. PubMed ID: 32418874
    [TBL] [Abstract][Full Text] [Related]  

  • 72. How many COVID deaths are acceptable in a post-pandemic world?
    Mallapaty S
    Nature; 2021 May; 593(7859):326-327. PubMed ID: 33958788
    [No Abstract]   [Full Text] [Related]  

  • 73. Genetic Diversity of SARS-CoV-2 among Travelers Arriving in Hong Kong.
    Gu H; Chu DKW; Chang LDJ; Cheuk SSY; Gurung S; Krishnan P; Ng DYM; Liu GYZ; Wan CKC; Xie R; Cheng SSM; Cowling BJ; Tsang DNC; Peiris M; Dhanasekaran V; Poon LLM
    Emerg Infect Dis; 2021 Oct; 27(10):2666-2668. PubMed ID: 34545799
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Association of Simulated COVID-19 Policy Responses for Social Restrictions and Lockdowns With Health-Adjusted Life-Years and Costs in Victoria, Australia.
    Blakely T; Thompson J; Bablani L; Andersen P; Ait Ouakrim D; Carvalho N; Abraham P; Boujaoude MA; Katar A; Akpan E; Wilson N; Stevenson M
    JAMA Health Forum; 2021 Jul; 2(7):e211749. PubMed ID: 35977202
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tourism under the Early Phase of COVID-19 in Four APEC Economies: An Estimation with Special Focus on SARS Experiences.
    Tran BL; Chen CC; Tseng WC; Liao SY
    Int J Environ Res Public Health; 2020 Oct; 17(20):. PubMed ID: 33081403
    [TBL] [Abstract][Full Text] [Related]  

  • 76. SARS-CoV-2 infection in children undergoing oncologic treatment in Hong Kong: A population-based cohort during the Omicron wave.
    Liu APY; Lam GKS; Chan WYK; Chow TTW; Cheung J; Wong SCY; Leung W; Lee PPW; Cheng FWT; Chan GCF
    Pediatr Blood Cancer; 2023 Feb; 70(2):e29894. PubMed ID: 35851745
    [No Abstract]   [Full Text] [Related]  

  • 77. Public health experts are learning from Canada's anti-mask protests.
    Hapuhennedige S
    CMAJ; 2020 Oct; 192(42):E1274-E1275. PubMed ID: 33077526
    [No Abstract]   [Full Text] [Related]  

  • 78. A government concerned with health disparities would not lift almost all covid-19 protections.
    Sweeney S
    BMJ; 2022 Mar; 376():o683. PubMed ID: 35292530
    [No Abstract]   [Full Text] [Related]  

  • 79. Learning to live with COVID-19 in Australia: time for a new approach.
    Bennett CM
    Public Health Res Pract; 2021 Sep; 31(3):. PubMed ID: 34494070
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Time to
    Yung CF; Saffari E; Liew C
    Epidemiol Infect; 2020 Dec; 148():e301. PubMed ID: 33292890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.